Jeffrey Lloyd Lennox MD
HIV/AIDS Medicine
Professor Emeritus Emory University School of Medicine Senior Director Gilead Sciencs
Join to View Full Profile
69 Jesse Hill Jr Dr SEFaculty Office BuildingAtlanta, GA 30303
Phone+1 404-251-8784
Dr. Lennox is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jeffrey Lennox, based in Atlanta, GA, specializes in Infectious Disease with a subspecialty in HIV/AIDS Medicine. He graduated from the University of Colorado School of Medicine Anschutz Medical Campus in 1983, completed his residency in Internal Medicine, and fellowship in Infectious Disease at the National Capital Consortium by 1988. His publications focus on HIV/AIDS and related pharmacology, with contributions to journals such as The Journal of Infectious Diseases and Clinical Infectious Diseases. He has authored studies exploring topics like antiretroviral therapy and bone loss, with his work being cited multiple times. Dr. Lennox has also been involved in clinical trials that investigate HIV infection, antiretroviral treatment effects, and vaccine efficacy in HIV-infected individuals.
Education & Training
National Capital ConsortiumFellowship, Infectious Disease, 1986 - 1988- National Capital ConsortiumResidency, Internal Medicine, 1983 - 1986
University of Colorado School of Medicine Anschutz Medical CampusClass of 1983
Certifications & Licensure
GA State Medical License 1994 - 2027
CO State Medical License 1988 - 1995
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination Start of enrollment: 2006 Mar 01
- Comparative Study of Three NNRTI-Sparing HAART Regimens Start of enrollment: 2009 May 01
- Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy Start of enrollment: 2009 Apr 29
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsEffect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral Therapy.Elizabeth Hastie, Carlee Moser, Xin Sun, Jeffrey Lennox, Priscilla Y Hsue
The Journal of Infectious Diseases. 2023-06-28 - 2 citationsPharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 StudySelwyn J. Hurwitz, Sijia Tao, Christina Gavegnano, Yong Jiang, Randall Tressler
Journal of Clinical Pharmacology. 2021-07-23 - 15 citationsDeveloping Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19.Safia S Kuriakose, Kanal Singh, Alice K. Pau, Eric S. Daar, Rajesh T. Gandhi
Annals of Internal Medicine. 2021-06-15
Press Mentions
Emory Receives NIH Funding for HIV Clinical Trials Unit, Including Four HIV/AIDS Clinical Research SitesDecember 1st, 2020
Emory-CDC HIV Clinical Trials Group Leads Studies in Four Countries Through NIH NetworksDecember 1st, 2017
Charlie Sheen Is Back on His HIV Meds After Seeking Alternative TreatmentsJanuary 13th, 2016- Join now to see all
Grant Support
- Emory HIV/AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases2007–2012
- Clinical ResearchNational Institute Of Allergy And Infectious Diseases2007–2011
- ACTG A5211National Center For Research Resources2007
- ACTG A5202: HIV In Newly Infected SubjectsNational Center For Research Resources2007
- ACTG A5164National Center For Research Resources2007
- ACTG A5157National Center For Research Resources2007
- ACTG A5146National Center For Research Resources2007
- ACTG A5142National Center For Research Resources2007
- ACTG A5001: AllrtNational Center For Research Resources2007
- ACTG 362National Center For Research Resources2007
- A5210: Phase Ib/Iia Dose-Finding Safety And Activity Study Of Amd11070National Center For Research Resources2007
- Project 3: Clinical TrialsNational Center For Research Resources2003–2006
- Efavirenz, Nevirapine, Nevirapine, And Lopinavir/Ritonavir In HIV DialysisNational Center For Research Resources2005
- Project 3: Vaccine DevelopmentNational Center For Research Resources2004
- Clinical TrialsNational Institute Of Allergy And Infectious Diseases2001–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
